CONMED Corp — Director's Dealing 2017

May 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-05-15

Reporting Person: TRYNISKI MARK E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-15	Common Stock	M	2500	$30.04	Acquired	29500	Direct
2017-05-15	Common Stock	F	1475	$50.94	Disposed	28025	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-15	Sars (Stock Appreciation Rights)	$30.04	M	2500	Disposed	2017-05-18	Common Stock (2500)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan,
with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's
termination of service provided the Director has completed one full year of service since the date of the award in which
case the SARs shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of
such termination, whichever period is shorter.